USD 1.36 Billion
Biopharmaceuticals Excipients Market Size, Share, Growth Analysis, By Dosage Form(Bare Metal Stents (BMS), Drug-Eluting Stents (DES), and Bioresorbable Vascular Scaffold (BVS) Solid, semi-solid), By End user(Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organizations and Academics, and Others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2197 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
66
|Figures:
75
Biopharmaceuticals Excipients Market Insights
Biopharmaceuticals Excipients Market size was valued at USD 1.44 Billion in 2022 and is poised to grow from USD 1.522 Billion in 2023 to USD 2.37 Billion by 2031, at a CAGR of 5.70% during the forecast period (2024-2031).
The global biopharmaceuticals excipients market has been experiencing steady growth and is a critical component of the pharmaceutical industry. The market's growth is primarily driven by the increasing demand for biopharmaceutical drugs, the growing focus on personalised medicine, and advancements in biotechnology and drug delivery systems. One of the key drivers of the market is the rising prevalence of chronic diseases such as cancer, autoimmune disorders, and infectious diseases, which has led to an escalated demand for biopharmaceuticals. These specialised drugs offer targeted and more effective treatments, leading to improved patient outcomes and reduced side effects compared to conventional pharmaceuticals. Furthermore, the growing adoption of biologics over small-molecule drugs and the development of innovative biotechnological drugs have spurred the demand for biopharmaceutical excipients. As research and development activities in the biopharmaceutical sector continue to thrive, the demand for specialised excipients that can cater to the unique requirements of biologic drugs is expected to increase. Despite the positive market prospects, the biopharmaceuticals excipients market also faces challenges. One major challenge is the complex and stringent regulatory landscape governing biopharmaceuticals and their excipients. The approval process for biologic drugs is rigorous, involving extensive testing and validation. Compliance with various regulatory standards and quality control requirements can pose significant barriers for excipient manufacturers, increasing their operational costs. Moreover, the high cost of biopharmaceuticals excipients compared to conventional pharmaceutical excipients is a limiting factor for their widespread adoption. The manufacturing process of biopharmaceutical excipients involves advanced technology and specialised facilities, which contributes to their higher cost.
US Biopharmaceuticals Excipients Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Solid
Fastest Growth
Solid
Growth Rate
5.70% CAGR
Global Biopharmaceuticals Excipients Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Biopharmaceuticals Excipients Market Segmental Analysis
The global biopharmaceuticals excipients market is segmented on the basis of dosage form, end user, and region. By dosage form, the market is segmented into Solid, Semi-Solid, and Liquid forms. By end user, the market is segmented into Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organizations and Academics, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Biopharmaceuticals Excipients Market Analysis By Dosage form
The global biopharmaceuticals excipients market can be segmented by dosage form into solid, semi-solid, and liquid forms. Among these segments, the dominant category in the biopharmaceuticals excipients market is the "Solid" dosage form. Solid excipients are widely used in the formulation of biopharmaceutical drugs, especially for oral solid dosage forms such as tablets and capsules. These excipients serve various purposes, including improving drug stability, enhancing drug solubility, and facilitating controlled drug release. The solid dosage form is preferred for its ease of manufacturing, stability, and patient compliance, making it a primary choice for many biologic drug formulations.
On the other hand, the fastest growing segment in the biopharmaceuticals excipients market is the "Liquid" dosage form. Liquid excipients play a crucial role in the formulation of biopharmaceutical drugs, particularly in parenteral and ophthalmic formulations. These excipients are essential for maintaining the stability and efficacy of biologic drugs in liquid forms, such as injectables and eye drops. The growing adoption of biopharmaceuticals administered through injections and other liquid routes is driving the demand for liquid excipients, making this segment the fastest-growing in the market.
Biopharmaceuticals Excipients Market Analysis By End user
The global biopharmaceuticals excipients market can be segmented by end user into Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organizations and Academics, and Others. Among these segments, the dominant category in the biopharmaceuticals excipients market is "Pharmaceutical and Biopharmaceutical Companies." These companies are the primary consumers of biopharmaceutical excipients, as they are engaged in the research, development, and manufacturing of biologic drugs. Pharmaceutical and biopharmaceutical companies utilise excipients to optimise drug formulations, enhance drug stability, and ensure the efficacy and safety of their biologic products. With a significant focus on developing novel biopharmaceuticals and improving existing drug formulations, these companies drive substantial demand for a wide range of excipients.
On the other hand, the fastest growing segment in the biopharmaceuticals excipients market is "Research Organisations and Academics." As research in the field of biopharmaceuticals continues to expand, academic institutions and research organisations play an increasingly vital role. These entities conduct studies on biologic drugs, their formulations, and novel drug delivery systems, necessitating the use of biopharmaceutical excipients in their research endeavours. The growing academic and research activities in biopharmaceuticals contribute to the rising demand for excipients in this segment.
Global Biopharmaceuticals Excipients Market By Dosage form
To get detailed analysis on other segments, Request For Free Sample Report
Biopharmaceuticals Excipients Market Regional Insights
Among the regions, North America stood as the dominant market for biopharmaceuticals excipients. The United States and Canada have well-established pharmaceutical and biotechnology industries, with a significant focus on research and development of biologic drugs. The presence of major pharmaceutical companies and contract manufacturers in the region drove the demand for excipients used in biopharmaceutical formulations. Additionally, the robust regulatory framework and favourable reimbursement policies in North America further supported the market's growth.
The fastest-growing region in the biopharmaceuticals excipients market was the Asia-Pacific (APAC) region. Countries in this region, including China, India, Japan, and South Korea, were witnessing a surge in pharmaceutical and biotechnology investments. The rising healthcare infrastructure, increasing healthcare expenditure, and expanding patient population with chronic diseases were driving the demand for biopharmaceutical drugs, subsequently fueling the need for excipients in the region. Moreover, the growing awareness of personalised medicine and targeted therapies in APAC contributed to the rising adoption of biopharmaceuticals and their excipients.
Global Biopharmaceuticals Excipients Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Biopharmaceuticals Excipients Market Dynamics
Biopharmaceuticals Excipients Market Drivers
Growing Demand for Biopharmaceuticals
- The increasing prevalence of chronic diseases, coupled with the rising aging population, has led to a surge in the demand for biopharmaceutical drugs. Biologics offer targeted and more effective treatments, driving the need for specialised excipients to enhance drug stability, solubility, and delivery, thus propelling the market's growth.
Advancements in Biotechnology and Drug Delivery Systems
- Continuous advancements in biotechnology, drug delivery systems, and formulation technologies have expanded the applications of biopharmaceuticals. As a result, excipient manufacturers are developing novel excipients tailored to meet the specific requirements of biologic drugs, stimulating market growth.
Biopharmaceuticals Excipients Market Restraints
Complex Regulatory Landscape
- The approval process for biopharmaceutical drugs is stringent and complex, with rigorous testing and validation requirements for excipients used in biologic formulations. Compliance with various regulatory standards poses challenges for excipient manufacturers, potentially hindering market growth.
Higher Cost of Biopharmaceuticals Excipients
- The manufacturing process of excipients for biopharmaceuticals involves advanced technologies and specialised facilities, leading to higher production costs compared to conventional pharmaceutical excipients. The higher cost of biopharmaceutical excipients can impact their adoption, particularly in resource-limited settings.
Request Free Customization of this report to help us to meet your business objectives.
Biopharmaceuticals Excipients Market Competitive Landscape
The global biopharmaceuticals excipients market features a highly competitive and dynamic landscape, driven by the increasing demand for biologic drugs and the continuous advancements in pharmaceutical technology. The market is characterised by the presence of numerous excipient manufacturers and suppliers, each vying for market share and striving to provide innovative solutions to pharmaceutical and biopharmaceutical companies. Companies in the excipients market compete based on product offerings, product quality, technological advancements, and pricing strategies. To gain a competitive edge, excipient manufacturers often invest heavily in research and development to develop specialised excipients that cater to the unique requirements of biologic drug formulations. Moreover, strategic partnerships, collaborations, and acquisitions are common practices in the market, enabling companies to expand their product portfolios and geographic reach. The focus on regulatory compliance and adherence to stringent quality standards are critical factors in the competitive landscape. Companies that can meet and exceed regulatory requirements and maintain consistently high product quality are more likely to gain the trust and preference of pharmaceutical and biopharmaceutical companies.
Additionally, customer-centric strategies, such as offering comprehensive technical support, customised solutions, and efficient supply chain management, are crucial for gaining customer loyalty and retaining long-term business relationships. Excipient manufacturers that can effectively address the evolving needs of pharmaceutical companies and provide reliable, high-quality products and services are better positioned to thrive in this competitive market.
Biopharmaceuticals Excipients Market Top Player’s Company Profile
- Ashland Inc.
- BASF SE
- Croda International Plc
- DowDuPont Inc.
- Evonik Industries AG
- Roquette Frères
- Colorcon, Inc.
- FMC Corporation
- Kerry Group
- Lubrizol Corporation
- Merck KGaA
- Archer Daniels Midland Company (ADM)
- Innophos Holdings Inc.
- Pfanstiehl, Inc.
- Spectrum Chemical Manufacturing Corp.
- Signet Chemical Corporation Pvt. Ltd.
- Finar Limited
- JRS Pharma
- Cargill, Incorporated
- Croda International Plc
Biopharmaceuticals Excipients Market Recent Developments
- In January 2023, Roquette Frères announced the launch of its new biopharmaceutical excipients facility in France. This facility is designed to produce high-quality biopharmaceutical excipients that meet the needs of the global market.
- In February 2023, Evonik Industries announced the expansion of its biopharmaceutical excipients production facility in Germany. This expansion will help to meet the growing demand for biopharmaceutical excipients in the global market.
Biopharmaceuticals Excipients Key Market Trends
- Increased Demand for Specialty and Functional Excipients: There was a growing demand for specialised excipients tailored to the unique requirements of biopharmaceutical formulations. Specialty excipients with functionalities such as protein stabilisation, controlled drug release, and improved solubility were gaining popularity as biologic drugs continued to advance.
- Rising Focus on Quality and Regulatory Compliance: The pharmaceutical industry's focus on quality and regulatory compliance extended to excipients used in biopharmaceuticals. Manufacturers and suppliers were aligning their products with stringent regulatory standards, ensuring safety, efficacy, and consistency in drug formulations.
Biopharmaceuticals Excipients Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global biopharmaceuticals excipients market analysis, the increasing demand for biologic drugs and the continuous evolution of pharmaceutical technology are the key growth drivers. The market has witnessed a surge in the adoption of specialty and functional excipients tailored to meet the specific requirements of biopharmaceutical formulations. Manufacturers have focused on quality and regulatory compliance, ensuring excipients' safety and efficacy in drug formulations. Moreover, the development of excipients for novel drug delivery systems, patient-centric formulations, and the adoption of plant-based and nanotechnology-driven excipients have shaped the market's dynamics. Sustainability and environmental concerns have also influenced the market, leading to a focus on eco-friendly and sustainable excipient sourcing and manufacturing practices. Excipient manufacturers have actively engaged in research and development to innovate and introduce excipients with advanced functionalities to cater to the evolving needs of biopharmaceuticals. Continuous manufacturing and collaborations between academia and industry have further contributed to the market's growth and innovation. However, the market also faces challenges related to complex regulatory standards, the high cost of specialised excipients, and limited availability of certain excipients. Addressing these challenges and capitalising on the emerging trends will be crucial for excipient manufacturers to maintain their competitive edge and sustain growth in the global biopharmaceuticals excipients market.
As the biopharmaceutical industry continues to expand and new technologies and drug delivery systems emerge, the demand for innovative excipients is expected to rise. Excipient manufacturers will need to stay agile, compliant with evolving regulatory norms, and invest in research and development to keep pace with the changing landscape and unlock the market's full potential. Overall, the Global Biopharmaceuticals Excipients Market presents a promising outlook with opportunities for excipient manufacturers to play a pivotal role in advancing the development and delivery of biologic drugs and contributing to improved patient outcomes and personalised medicine.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.44 Billion |
| Market size value in 2031 | USD 2.37 Billion |
| Growth Rate | 5.70% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Biopharmaceuticals Excipients Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Biopharmaceuticals Excipients Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Biopharmaceuticals Excipients Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Biopharmaceuticals Excipients Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Biopharmaceuticals Excipients Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Biopharmaceuticals Excipients Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
